CNMD - コンメド （CONMED Corporation） コンメドCNMDのチャート
CNMDの企業情報
| symbol | CNMD |
|---|---|
| 会社名 | Conmed Corp. （コンメド） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 コンメッド（CONMED Corporation）は医療技術会社である。同社は外科用機器および関連機器の開発、製造および販売に従事する。同社は低侵襲性治療用外科用器具を提供する。同社の製品は整形外科、一般外科、婦人科、脳神経外科、胃腸病学などの専門分野で外科医・医師に使用される。同社の製品ラインは整形外科手術、一般外科手術、手術視覚化を含む。同社の整形外科用製品ラインにはスポーツ医学、動力付き外科用器具、スポーツ用の生物製剤と組織が含まれる。同社の製品は「Hall」、「CONMED Linvatec」、「Concept」、「Shutt」を含むブランドで販売される。 コンメドは米国の手術器具や装置に特化した大手医療品メ―カ―。内視鏡などの腹腔鏡手術や、そのほかの整形外科市場向けの受電手術器具、心臓モニタリング及び血液酸素化モニタリング用ECG電極製品、手術用電動ノコギリ、ドリル、発電機などを提供する。本社はニューヨーク州ウティカ。 conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500 |
| 本社所在地 | 525 French Road Utica NY 13502 USA |
| 代表者氏名 | Mark E. Tryniski マークE.トゥリニスキ |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 315-624-3215 |
| 設立年月日 | 25600 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 1987年 |
| 従業員数 | 3100人 |
| url | www.conmed.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cnmd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 125.32100 |
| 終値（lastsale） | 73.67 |
| 時価総額（marketcap） | 2070919320.85 |
| 時価総額 | 時価総額（百万ドル） 259.956 |
| 売上高 | 売上高（百万ドル） 827.55600 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 2485.742 |
| 当期純利益 | 当期純利益（百万ドル） 41.36900 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 CONMED Corporation revenues increased 8% to $414.9M. Net income increased from $1.6M to $19.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Restructuring decrease from $19M (expense) to $0K Derivatives increase from $1.8M to $5.9M (income) Restructuring - COGS decrease from $1.5M (expense) to $0K. |
CNMDのテクニカル分析
CNMDのニュース
The USA Knotless Surgical Sutures Market is Expected to Reach a Valuation of US$ 258.7 million by 2033, with a Steady Growth Rate of 3.6% CAGR: Future Market Insights, Inc. 2023/05/25 09:16:00 Accesswire
NEWARK, DE / ACCESSWIRE / May 25, 2023 / As per Future Market Insights'' latest industry analysis, the valuation for the USA knotless surgical sutures market was around US$ 175.7 Million in 2022 and is projected to exhibit a CAGR growth of close to 3.6% over the forecast period, with an estimated valuation of US$ 258.7 Million in 2033. Over the years, the USA market for knotless surgical sutures has seen tremendous growth. Key factors driving the market include technological advancements in terms of the usage of synthetic materials in creating surgical sutures, the development of absorbable sutures, increasing export opportunities, and rising disposable income. For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2033 - Download a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17299 Leading companies are inclined towards extensive research in order to develop new and improved versions of knotless surgical sutures. These include sutures with synthetic materials to provide exceptional tissue holding properties, sutures with properties like antibacterial or Triclosan-coated polyglactin 910 coated sutures, barbed sutures, sutures with braiding technologies, or absorbable sutures made of fibresthat line animal intestines or artificially created polymers.
CL King initiates coverage of CONMED at ''buy'' with a price target of $140.00 2023/05/22 11:42:37 Investing.com
https://www.investing.com/news/pro/conmed-corp-receives-investment-bank-analyst-rating-update-3087737
Conmed: Updated Guidance Is Positive 2023/05/19 19:06:38 Seeking Alpha
Conmed has performed as expected, with the stock price nearing the previously set target of $142. Read why CNMD should be on your watchlist.
Brinker Capital Investments LLC Sells 1,250 Shares of CONMED Co. (NYSE:CNMD) 2023/05/05 12:12:42 The AM Reporter
Brinker Capital Investments LLC reduced its stake in shares of CONMED Co. (NYSE:CNMD – Get Rating) by 13.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,983 shares of the company’s stock after selling 1,250 shares during […]
Conmed Recent Insider Activity 2023/05/03 15:06:43 Benzinga
Peter K Shagory , EVP at Conmed (NYSE: CNMD ), reported a large insider sell on May 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Shagory sold 2,442 shares of Conmed . The total transaction amounted to $312,576. Conmed shares are trading down 0.03% at $124.84 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com
The USA Knotless Surgical Sutures Market is Expected to Reach a Valuation of US$ 258.7 million by 2033, with a Steady Growth Rate of 3.6% CAGR: Future Market Insights, Inc. 2023/05/25 09:16:00 Accesswire
NEWARK, DE / ACCESSWIRE / May 25, 2023 / As per Future Market Insights'' latest industry analysis, the valuation for the USA knotless surgical sutures market was around US$ 175.7 Million in 2022 and is projected to exhibit a CAGR growth of close to 3.6% over the forecast period, with an estimated valuation of US$ 258.7 Million in 2033. Over the years, the USA market for knotless surgical sutures has seen tremendous growth. Key factors driving the market include technological advancements in terms of the usage of synthetic materials in creating surgical sutures, the development of absorbable sutures, increasing export opportunities, and rising disposable income. For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2033 - Download a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17299 Leading companies are inclined towards extensive research in order to develop new and improved versions of knotless surgical sutures. These include sutures with synthetic materials to provide exceptional tissue holding properties, sutures with properties like antibacterial or Triclosan-coated polyglactin 910 coated sutures, barbed sutures, sutures with braiding technologies, or absorbable sutures made of fibresthat line animal intestines or artificially created polymers.
CL King initiates coverage of CONMED at ''buy'' with a price target of $140.00 2023/05/22 11:42:37 Investing.com
https://www.investing.com/news/pro/conmed-corp-receives-investment-bank-analyst-rating-update-3087737
Conmed: Updated Guidance Is Positive 2023/05/19 19:06:38 Seeking Alpha
Conmed has performed as expected, with the stock price nearing the previously set target of $142. Read why CNMD should be on your watchlist.
Brinker Capital Investments LLC Sells 1,250 Shares of CONMED Co. (NYSE:CNMD) 2023/05/05 12:12:42 The AM Reporter
Brinker Capital Investments LLC reduced its stake in shares of CONMED Co. (NYSE:CNMD – Get Rating) by 13.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,983 shares of the company’s stock after selling 1,250 shares during […]
Conmed Recent Insider Activity 2023/05/03 15:06:43 Benzinga
Peter K Shagory , EVP at Conmed (NYSE: CNMD ), reported a large insider sell on May 2, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Shagory sold 2,442 shares of Conmed . The total transaction amounted to $312,576. Conmed shares are trading down 0.03% at $124.84 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com
Analyst Impressed With CONMED''s Upbeat Q1 Performance and Raised Guidance, Bullish On Organic Growth 2023/04/27 19:18:56 Benzinga
CONMED Corporation (NYSE: CNMD ) shares are trading higher after the company reported better-than-expected Q1 earnings . It reported Q1 adjusted EPS of $0.66, beating the consensus of $0.60 but down 5.7% Y/Y. The Q1 sales came in at $295.47 million, up 21.9% (25.1% in constant currency), surpassing the consensus of $266.67 million. The company raised FY23 revenue guidance to $1.205-$1.250 billion from $1.170-$1.220 billion expected earlier, versus the consensus of $1.19 billion. FY23 adjusted EPS is expected to be $3.30 to $3.50, compared to its prior range of $3.20-$3.45 and … Full story available on Benzinga.com
CONMED Corporation 2023 Q1 - Results - Earnings Call Presentation (NYSE:CNMD) 2023/04/27 03:06:57 Seeking Alpha
The following slide deck was published by CONMED Corporation in conjunction with their 2023 Q1 earnings call.
CONMED Corporation (CNMD) Q1 2023 Earnings Call Transcript 2023/04/27 03:06:02 Seeking Alpha
CONMED Corporation (NYSE:NYSE:CNMD) Q1 2023 Results Earnings Conference Call April 27, 2023 4:30 PM ETCompany ParticipantsCurt Hartman - Chair of the Board, President, and Chief Executive…
CONMED Q1 results beat estimates, co raises FY 2023 guidance 2023/04/26 21:10:15 Seeking Alpha
CONMED press release (CNMD): Q1 Non-GAAP EPS of $0.66 beats by $0.06.Revenue of $295.5M (+21.9% Y/Y) beats by $28.84M.Now expects FY 2023 revenue between $1.205 billion and…
Global Electrosurgery Generators Market Growth is accelerating due to Growing Popularity of Minimally Invasive Surgeries | Future Market Insights, Inc. 2023/04/25 16:20:00 Accesswire
NEWARK, DE / ACCESSWIRE / April 25, 2023 / The global Electrosurgery Generator Market is predicted to be worth US$ 1.6 Billion in 2023, and to grow at a CAGR of 7.7% to be worth US$ 3.4 Billion by the end of 2033. Changing the electrical current that the electrosurgical generating units (ESU) produce into heat energy within tissue is a process known as electrosurgery. The rise in surgical procedures is one of the key factors anticipated to propel the growth of the market for electrosurgical generators during the forecast period. Demand for minimally invasive procedures as well as the rising ageing population further adds to the growth of the market. The ability to cut or cauterize tissue with a high-frequency electrical current makes electrosurgical generators (ESG) more and more common. Because it provides surgeons with a precise and controllable energy source during surgery, an ESG is essential. With the help of this electrical energy, the tissue is cut or coagulated. Electrosurgery Generator demand is expected to rise due to the demand for least invasive procedures.